SISAQOL‑IMI Training:

Standards for Designing, Analysing, Interpreting, and Presenting PRO Data in Cancer Clinical Trials

  • Author: Name
  • Level: Advanced
  • Study time: X hours
Write your awesome label here.
This e‑learning course provides an introduction to the SISAQOL‑IMI international consensus recommendations for patient‑reported outcomes (PRO) and health‑related quality of life (HRQOL) in cancer clinical trials. Through expert-led presentations, the course guides participants through the core elements of the SISAQOL‑IMI framework. Learners will become familiar with how to define PRO objectives, apply the estimand framework, describe key PRO concepts and endpoints, predefine and document strategies for handling intercurrent events and missing data, and ensure transparent, standardised, and reproducible reporting of PRO analyses for scientific, regulatory, and patient‑focused audiences.

What is included:

  • Clear and well‑defined PRO research objectives are essential—they must be aligned with the estimand framework to ensure appropriate design, analysis, and interpretation of PRO data. 
  • Handling intercurrent events (especially death) must be predefined and justified, as different strategies lead to different interpretations of treatment effects. 
  • Missing data and intercurrent events must be distinguished, with sensitivity and supplementary analyses required to ensure robust conclusions. 
Empty space, drag to resize
  • Repeated cross‑sectional or simple imputation methods are discouraged; longitudinal modelling and appropriate handling of uncertainty are recommended. 
  • Clinically meaningful change requires harmonized, fit‑for‑purpose thresholds, clearly differentiated for patient‑level and group‑level interpretation. 
  • Presentation of PRO results must follow consistent, transparent visual standards, including full scale ranges, directionality indicators, sample size reporting, and clear separation of confirmatory vs. exploratory findings. 

Course Content

TEAM

Our Faculty

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Madeline Pe

Head of the Quality of Life Department at the EORTC 

Corneel Coens

Lead statistician at the EORTC

Michael Schlichting

Director Biostatistics at Merck KGaA. Global

Madeline Pe

Head of the Quality of Life Department at the EORTC 

Corneel Coens

Lead statistician at the EORTC

Michael Schlichting

Director Biostatistics at Merck KGaA. Global